Forest Labs nears $3 bln deal for Aptalis -source

Jan 7 (Reuters) - Forest Laboratories Inc is nearing an agreement to acquire specialty pharmaceutical company Aptalis Holdings Inc from private equity firm TPG Capital LP for about $3 billion, a person familiar with the matter said on Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.